SCHEMBL7002028

SCHEMBL7002028

N#CC1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 13/20 0.73
ERBB2 P04626 6/20 0.73
HPGD P15428 1/20 0.73
HTT P42858 1/20 0.73
CSNK2A1 P68400 1/20 0.53
MAPT P10636 1/20 0.50
GRM1 Q13255 1/20 0.46
BCL6 P41182 2/20 0.44
BRAF P15056 3/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ERBB4 Q15303 1/20 0.42
AURKA O14965 1/20 0.41
INSR P06213 1/20 0.41
FBP1 P09467 1/20 0.41
PDGFRB P09619 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
CLK1 P49759 1/20 0.41
EPHB4 P54760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8314263 0.92 EGFR (0.84) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6990181 0.88 EGFR (0.80) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6997215 0.88 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL7587481 0.88 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL8316770 0.88 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6995190 0.88 EGFR (0.80) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6992157 0.88 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6997208 0.88 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL6999445 0.86 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1
SCHEMBL7092722 0.86 EGFR (0.77) EGFRERBB2HPGDHTTCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888351-B1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION THOMAE GMBH DR K (DE) 2003-10-15 EP disclosed
EP-0888351-A1 PYRIMIDO 5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION Dr. Karl Thomae GmbH (DE) 1999-01-07 EP disclosed
WO-1997032880-A1 PYRIMIDO[5,4-D]PYRIMIDINES, MEDICAMENTS CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PRODUCTION DR. KARL THOMAE GMBH (DE) 1997-09-12 WO disclosed